Akebia Therapeutics' Series B Round

Akebia Therapeutics raised a round of funding on April 26, 2011.

Akebia Therapeutics is a biopharmaceutical company focused on the development of small molecules for the treatment of anemia and vascular disease. The company's lead compound, AKB-6548, is a once dail…

Articles about Akebia Therapeutics' Series B Round: